GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Argenica Therapeutics Ltd (ASX:AGN) » Definitions » Purchase Of Investment

Argenica Therapeutics (ASX:AGN) Purchase Of Investment : A$0.00 Mil (TTM As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Argenica Therapeutics Purchase Of Investment?

Argenica Therapeutics's purchase of investment for the six months ended in Dec. 2023 was A$0.00 Mil. It means Argenica Therapeutics spent A$0.00 Mil on purchasing investments. Argenica Therapeutics's purchase of investment for the trailing twelve months (TTM) ended in Dec. 2023 was A$0.00 Mil.

Compared with last quarter (A$0.00 Mil in Jun. 2023 ), Argenica Therapeutics spent the same money on purchasing investments in Dec. 2023 (A$0.00 Mil).


Argenica Therapeutics Purchase Of Investment Historical Data

The historical data trend for Argenica Therapeutics's Purchase Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Argenica Therapeutics Purchase Of Investment Chart

Argenica Therapeutics Annual Data
Trend Jun21 Jun22 Jun23 Jun24
Purchase Of Investment
- - -0.05 -

Argenica Therapeutics Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Purchase Of Investment Get a 7-Day Free Trial - - - - -

Argenica Therapeutics Purchase Of Investment Calculation

Purchase of Investments represents cash outflow on the purchase of investments in securities.

Purchase Of Investment for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Argenica Therapeutics Purchase Of Investment Related Terms

Thank you for viewing the detailed overview of Argenica Therapeutics's Purchase Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.


Argenica Therapeutics Business Description

Traded in Other Exchanges
N/A
Address
117 Broadway, Unit 4, Nedlands, WA, AUS, 6009
Argenica Therapeutics Ltd is engaged in the development and commercialization of novel drug candidates. Its ARG007 drug improves outcomes in pre-clinical stroke models and is in the process of being verified for its safety and toxicology before commencing Phase 1 clinical trials in humans.

Argenica Therapeutics Headlines

No Headlines